Each of 50 tested strains of Neisseria gonorrhoeae produced growth-inhibitory substances that were active against most strains of gonococci or meningococci, but not against species other than the Neisseria. There were quantitative differences among different strains in production of the inhibitor and sensitivity to it, but not of sufficient magnitude to permit routine strain typing. The inhibitor was associated with the cell pellet (crude cell envelope) and was not inducible with mitomycin C. Inhibitory activity was thermostable and resisted alkali and proteolytic enzymes. The inhibitor was quantitatively recovered from whole cells by chloroform-methanol extraction. Separation of total gonococcal lipids by silica gel chromatography revealed inhibitory activity in both the free fatty acid and the phospholipid fractions. The major phospholipid, phosphatidylethanolamine, had no inhibitory activity, but monoacyl phosphatidylethanolamine, a minor phospholipid, was quite inhibitory. It is likely that the "bacteriocin" of N. gonorrhoeae strains results from the degradation of phosphatidylethanolamine to inhibitory long-chain free fatty acids and monoacyl phosphatidylethanolamine.
Each of 50 tested strains of Neisseria gonorrhoeae produced growth-inhibitory substances that were active against most strains of gonococci or meningococci, but not against species other than the Neisseria. There were quantitative differences among different strains in production of the inhibitor and sensitivity to it, but not of sufficient magnitude to permit routine strain typing. The inhibitor was associated with the cell pellet (crude cell envelope) and was not inducible with mitomycin C. Inhibitory activity was thermostable and resisted alkali and proteolytic enzymes. The inhibitor was quantitatively recovered from whole cells by chloroform-methanol extraction. Separation of total gonococcal lipids by silica gel chromatography revealed inhibitory activity in both the free fatty acid and the phospholipid fractions. The major phospholipid, phosphatidylethanolamine, had no inhibitory activity, but monoacyl phosphatidylethanolamine, a minor phospholipid, was quite inhibitory. It is likely that the "bacteriocin" of N. gonorrhoeae strains results from the degradation of phosphatidylethanolamine to inhibitory long-chain free fatty acids and monoacyl phosphatidylethanolamine.
There is no satisfactory means for classifying clinical isolates of Neisseria gonorrhoeae. Bacteriocin typing has been used to classify several species of bacteria including Escherichia coli and Pseudomonas aeruginosa. (6, 24) . This method is dependent upon the production of a proteinaceous antibacterial substance that exhibits strain-specific growth inhibition of members of the same, or closely related, species. In 1966 Kingsbury (17) isolated a bacteriocin from a strain of N. meningitidis, and Counts et al. (3) subsequently employed bacteriocin typing of meningococci as an epidemiological tool. Flynn and McEntegart recently reported the apparent success of a similar "bacteriocin" typing scheme for gonococci (7) . In this report we explore the potential efficacy of strain typing gonococci by these methods and the mechanisms of growth inhibition between gonococci.
MATERIALS AND METHODS Microorganisms and media. Strains of N. gonorrhoeae included both recent clinical isolates from Durham, N.C., and older laboratory strains obtained from widely varying geographical regions of the United States, Europe, and Asia. (The latter were kindly supplied by R. Martin, Atlanta; A. Reyn, Copenhagen; and G. Brooks, Indianapolis, who also sent six strains used by Flynn and McEntegart [7] .) All strains were characterized as N. gonorrhoeae by Gram stain, oxidase reaction, and sugar fermentations. Strains of N. meningitidis were obtained locally from clinical sources, and their identity was confirmed by fermentation of glucose and maltose but not sucrose, lactose, or fructose. Colicin-producing and indicator strains of E. coli kindly supplied by J. K. Davies were: K53 (colicin El), CA42 (colicin E2), CA38 (colicin E3), K235 (colicin K), and AB1133 (indicator strain sensitive to colicins El, E2, E3, and K). Pyocin-producing (P1 and P10) and indicator strains (Ti and T5) of Pseudomonas aeruginosa were obtained from J. J. Farmer; the pyocin-producing strains were induced with mitomycin C as described by Farmer and Herman (6) . Strains of other species were from the local culture collection.
Cultures were stored at -70 C in Trypticase soy broth (BBL) containing 20% glycerol. Plate media used throughout was GC base medium (Difco) plus mal medium A of Davis and Mingioli (4) (minimal broth Davis, Difco) was prepared without glucose and was used for suspending and diluting cells. All cultures were incubated at 37 C in a 5% CO2 incubator.
Chemicals. Mitomycin C was from Mann Research. Fatty acids were purchased from Nu-ChekPrep Inc. (Elysian, Minn.). Phosphatidylethanolamine (PE) and monoacyl PE (lyso PE) were obtained from Applied Sciences Laboratories (State College, Pa.), and phosphatidylglycerol (PG) was from Supelco, Inc. (Bellefonte, Pa.). Monoacyl phosphatidycholine (PC) was prepared by treating PC from egg yolk with phospholipase A2 (26) , and the monoacyl PC was separated from the free fatty acids (FFA) before use by preparative thin-layer chromatography on silica gel by using a petroleum ether-diethyl ether-acetic acid developing solvent (70:30: 1). Pronase (grade B) was from Calbiochem. Bovine serum albumin was purchased from Sigma Chemical Co. (St. Louis) in two forms, purified fraction V and fatty acid free. All other chemicals were of highest available purity.
Inhibition of gonococci by whole cells or cell extracts. A replica-inoculating device was used to inoculate 11 to 21 "producer" strains onto agar plates (usually GCBDS). After incubation for 24 to 48 h, the plates were exposed to chloroform vapor for 1 min, and then overlaid with 0.2 ml of an indicator strain suspension (adjusted to 100 Klett units) in 3.0 ml of soft agar ("double-layer" technique [8] ). After overnight incubation, the size of the clear zone of inhibition of the indicator strain around each underlying producer strain was recorded. Most strains were also tested by the "cross-streaking" method described by Fredericq (9) and modified by Flynn (7) . Inhibition by extracts of whole cells or by purified reagents was determined by spotting 0.01 ml of the materials to be tested onto GCBDS plates, which were allowed to dry before being overlaid by the indicator strain in soft agar. Quantitation of inhibitory activity of suspensions of cells or of cell extracts was expressed as the highest dilution resulting in unequivocal growth inhibition. All tests were performed in duplicate. Mitomycin C induction of growth inhibitor. Eleven gonococcal strains exhibiting strong inhibition of other strains by the double-overlay or cross-streak methods were tested for mitomycin C inducibility of their putative bacteriocin (7) . Early log-phase cells were incubated at 33 C to 38 C for 5 h in broth containing 0.01 to 0.32 Ag of mitomycin C per ml.
The concentrations of mitomycin C were slightly less than the minimal growth-inhibiting concentration for each strain. After mitomycin induction, the cells were washed by centrifugation and incubated for another 17 h in fresh broth. The cells were then pelleted by centrifugation for 10 min at 20,000 x g, and the cell pellet and supernatant fluid were tested for inhibitory activity against sensitive indicator strains. Broth media included Trypticase soy broth, peptone broth, and Mueller-Hinton broth, with addition of 2% defined supplements (30) or 2% supplement C (Difco). Incubations were performed with varying degrees of aeration or environmental CO2. In some instances, samples were taken hourly during mitomycin C induction to detect possible presence of a labile growth inhibitor.
Attempts to solubilize the inhibitor. Strains resulting in definite growth inhibition of other gonococci were grown for 24 h on GCBDS plates, suspended in minimal medium A, and washed twice by centrifugation. Whole cells were ruptured at 0 C in a French pressure cell at 20,000 psi. Deoxyribonuclease (2 ,ug/ml) was added, and the cell pellet (crude envelope fraction) and supernatant were collected by centrifugation for 30 min at 30,000 x g (4 C). The cell pellet containing most of the inhibitor was washed twice, suspended, and stirred for 15 min to several hours at room temperature in one of several reagents described as being effective in removing proteins from membranous material (23) Pronase digestion. Whole gonococcal cells or the alkali-extracted inhibitor, soluble pyocins, and colicins were exposed to 2 mg of Pronase per ml in 0.02 M tris(hydroxymethyl)aminomethane-hydrochloride (pH 7.4) for 2 h at 37 C. Sensitivity of gonococcal growth inhibitor to Pronase produced during growth on GCBDS plates was determined in the double overlay technique by incorporating 2 mg of Pronase per ml in the soft agar overlay containing the indicator strain.
Quantitative lipid extraction of the inhibitor from whole cells. One to two grams of cells, removed by scraping from 24-h GCBDS plate cultures, was suspended in minimal medium A to a final volume of about 4.5 ml. A 2.0-ml volume of the cell suspension was set aside, and another 2.0-ml sample was pipetted into a Waring blender and extracted for lipids with chloroform-methanol (1: 2) essentially as described by Garbus (12) . Great care was taken to insure maximal recovery of the lipids; this included two additional chloroform washes of the cell material after acidification with 0.08 ml of 50% H2S04. The combined chloroform extracts were desiccated at room temperature under vacuum, and the lipids were resuspended in 2.0 ml of chloroform. Serial dilutions of the lipid solution and the control, unextracted cell suspension were tested for inhibitory activity as described.
Extraction and separation of the lipids. A 100-mg amount of lyophilized cells was suspended in 2. 10, 1974 GROWTH INHIBITION BETWEEN N. GONORRHOEAE STRAINS (100: 15, vol/vol) for phospholipids. Great care was taken to insure that the ITLC papers and the solvent were free of water. Such caution was necessary to achieve the separation of PG from PE. The chromatograms were dried and either charred with H2SO4 or developed with ninhydrin. Appropriate neutral and phospholipid standards were employed as controls.
Preparative thin layer chromatography was used in experiments to determine which lipids were growth inhibitory. A 1.5-ml volume of the lipid extract was concentrated, spotted onto Silica Gel G plates (0.25 mm), and developed with petroleum ether-ethyl ether-acetic acid (70:30: 1). The lipid bands were located by spraying only the part of the chromatogram containing the standards with 2, 7-dichlorofluorescein and using ultraviolet light. The bands representing the phospholipids,. the FFA, and the solvent front were scraped from the plate and eluted with chloroform-methanol (2: 1, vol/vol). The eluates were evaporated under vacuum or N2, suspended in chloroform, and tested for inhibition of growth of indicator strain FA5.
The fatty acid concentrations were determined on the total lipid extract of N. gonorrhoeae FA5 and N. meningitidis NM33 and on the FFA fraction from FA5. The procedure of Metcalf et al. (21) (25) . Arachidic acid (20:0) was used as an internal standard since only trace amounts of this acid were found. RESULTS Apparent bacteriocin production. Each of 50 tested strains of N. gonorrhoeae produced substances that inhibited the growth of other gonococci. The results were difficult to reproduce by the cross-streak method of Flynn and McEntegart (7), but were more reproducible by the double-overlay method (Fig. 1) . The size of the zone of inhibition of the indicator strain varied according to several variables. The omission of starch or the substitution of MuellerHinton medium for GCBDS resulted in larger zones of inhibition. Zone sizes and strain differences in production of inhibitor were maximized if the plates containing 24-h growth of producer strains were refrigerated for 48 h prior to the overlaying with the indicator strain. The clonal type (15) of the producer or the indicator strain had no significant effect on the amount of inhibition observed.
Some gonococci clearly showed a more noticeable growth inhibitory effect than others (Fig.  1 evidence for immunity of producer strains to their own inhibitors. Sensitivity to inhibition also varied, but the differences were relatively small. The differences in apparent production of inhibitor and in sensitivity to inhibition were sufficient for grouping strains into four arbitrary categories (either good or poor producer, or sensitive or resistant indicator), but further subdivisions were impossible.
Specificity of growth inhibition. The growth inhibitors produced by 12 tested strains of gonococci were active against each of the six strains of N. meningitidis tested, but not against one strain of N. lactamicus or against any of five strains each of E. coli, Enterobacter, Klebsiella, Proteus, group A streptococci, and Staphylococcus aureus. Two of five strains of P. aeruginosa were slightly inhibited.
Isolation of the inhibitor. All attempts to induce production of increased amounts of the growth inhibitor with mitomycin C were unsuccessful. No inhibitory activity was found in the supernatant of mitomycin-induced cultures, and the activity associated with the cell pellet was not increased.
When cells were disrupted by passage through a French press and then centrifuged at 30,000 x g for 30 min, nearly all of the inhibitory activity remained in the cell wall-enriched fraction (cell pellet) rather than in the superna-tant. When the cell pellet was exposed to neutral solutions (KCl or NaCl) of varying ionic strength (up to 5 M), or to butanol, no release of inhibitor was achieved. Partial release of the inhibitor from the cell pellet was achieved with 20 mM ethylenediaminetetraacetic acid or by mild alkali treatment (pH 8.0 to 10.0). Progressively greater release of inhibitor was achieved with more strongly alkaline buffers, and at pH 12 all cellular material was saponified, with complete recovery of inhibitory activity (alkali inhibitor).
Most of the inhibitor remained in the supernatant after a 60-min 100,000 x g centrifugation, and it was not dialyzable. Like gonococcal whole-cell suspensions, the alkali inhibitor was not affected by autoclaving (121 C) for 20 min or by digestion with deoxyribonuclease, Pronase, or trypsin. The alkali inhibitor was completely blocked by addition of 2% (wt/vol) bovine serum albumin and partially blocked by addition of 1% soluble starch (Difco) to the media used for testing inhibitory activity. In contrast, soluble colicins El, E2, E3, and K and two pyocins were completely inactivated by Pronase or autoclaving and were not affected by 2% bovine serum albumin or 1.0% starch (Table 1) .
Similar results were obtained when inhibition between whole cells was tested in agar medium containing Pronase or bovine serum albumin. The gonococcal inhibitors were unaffected by Pronase but inhibited by 2% bovine serum albumin, whereas colicins and pyocins were Pronase sensitive and bovine serum albumin resistant. Thus, the gonococcal inhibitor released into agar or prepared by alkaline digestion of whole cells or cell pellets differed in several important respects from classical bacteriocins and seemed unlikely to be a protein.
Strain typing with alkali inhibitor. Alkaline extraction of approximately 0.5 g (wet weight) of cells from 20 strains into a volume of 2.0 ml resulted in inhibitory titers of 1: 2 to 1 :8 when tested on GCBDS plates. The same inhibitors were bactericidal at dilutions of 1: 256 to 1:1,012 to cells growing exponentially in peptone broth. Differences in sensitivity to inhibition among the 20 strains were no greater than fourfold.
Lipid nature of gonococcal inhibitor. Chloroform-methanol extraction of washed, whole cells resulted in quantitative recovery of inhibitory activity (Table 2 ). Similar extraction of uninoculated agar plates or of N. meningitidis NM33 grown under identical conditions did not result in recovery of any inhibitory material. Therefore, the chloroform-extractable gonococcal inhibitor must have been the result of the endogenous metabolism of the strain and not an artifact resulting from presence of inhibitory lipids in the agar medium.
Chromatographic separation of the chloroform-methanol extracts revealed that the major lipid components of N. gonorrhoeae FA5 were FFA and phospholipids, whereas N. meningitidis NM33 showed only phospholipids (Fig. 2) . Similar results were obtained with each of seven other strains of N. gonorrhoeae tested in this manner; two of three additional strains of N. When the lipid components of the two strains were separated by preparative thin-layer chromatography and tested for inhibition,, both the FFAs and the phospholipids of FA5 were inhibitory, but the phospholipids of NM33 were not. Since the FFAs of FA5 were quite inhibitory, it became important to determine their concentration and composition. Analysis by gas-liquid chromatography showed that the FFA fraction meningitidis also displayed plentiful FFA on silica gel chromatograms. Thus, FFA were uniformly present in seven strains of N. gonorrhoeae, but were an inconstant finding among N. meningitidis strains.
When the phospholipids were separated in a more polar solvent, gonococcal strain FA5 and meningococcal strain NM33 again appeared to differ (Fig. 3) . Both strains contained PG and PE, but FA5 appeared to have small quantities of two other compounds. When another chromatogram of the separated phospholipids was of FA5 constituted about 20% of the total fatty acids and that the FFA composition differed considerably from that of the total fatty acids ( The sensitivity of N. gonorrhoeae and N. meningitidis to purified FFAs of differing structure is shown in Table 4 . Representative strains of both species were more sensitive to mediumand long-chain fatty acids than to short-chain fatty acids. Methyl esters of the major FFAs were not inhibitory, nor was the major phospholipid of both strains, PE. However, the monoacyl derivative of PE was quite inhibitory and, therefore, likely to be responsible for the inhibition produced by FA5's phospholipid fraction.
A representative mixture of the major fatty acids found in the FFA fraction of N. gonorrhoeae strain FA5 was prepared with the following final concentrations: 18:0, 1.3 mM; 18:1, 3.8 mM; 16:0, 3.1 mM; and 16:1, 6.0 mM. This solution was inhibitory to FA5 at a dilution of 1: 16 and to NM33 at a dilution of 1: 64, but had no effect on a strain of N. lactamicus which was resistant to growth inhibition by gonococci.
DISCUSSION
We sought to determine whether gonococci produced bacteriocins that could be used as the basis of a strain-typing system. The results showed that each of 50 strains of N. gonorrhoeae produced inhibitory substances effective against gonococci and meningococci, but not against other species of bacteria. However, the differences among strains in production of and sensitivity to the inhibitor were too small to permit reliable strain typing. Our results do not substantiate, therefore, the report by Flynn and McEntegart that nearly 75 of 100 strains of gonococci could be separated into 13 types on the basis of differences in patterns of inhibition observed by the cross-streak method (7) . Since the strains used in this study included several of the indicator strains used by Flynn and McEntegart (7), our failure to confirm their findings is not likely to be solely the result of strain differences, nor are the differences likely to be due to conditions of culture since they were essentially the same (7) .
The results presented here suggest strongly that production of true bacteriocins (24) by gonococci is quite uncommon. The inhibitors produced by gonococci were not mitomycin C inducible, and they resisted Pronase digestion and autoclaving. Their activity was blocked by starch or albumin, two compounds capable of absorbing or forming complexes with lipids (13, 18) . These properties of the gonococcal inhibitor were unlike those demonstrated for known colicins and pyocins ( Table 1 ) and suggested that the inhibitor might be lipid or lipopolysaccharide (13, 18, 19) . This was confirmed by quantitative recovery of inhibitor by lipid extraction procedures and by demonstration that the lipid extracts contained inhibitory long-chain FFA and phospholipids.
In 1947 Ley and Mueller described the presence in agar media of fatty acids inhibitory to gonococci and showed that this inhibition was overcome by addition of starch to the medium (18). They also described differences in strain susceptibility to inhibition by fatty acids (18). Brooks et al. found that "spent" GCBDS media (on which gonococci had been grown) contained increased amounts of medium-and long-chain fatty acids (C10 to C18) compared to uninoculated media (2) . We have extended these obser- 10, 1974 vations by showing that up to 20% of gonococcal fatty acids are in the free (unesterified) form and that the diffusion of lipids into the medium accounts for growth inhibition when gonococci are tested for bacteriocin production by standard methods. Our observations also suggest a similar mechanism may explain a part of the growth inhibition between certain meningococci.
It is well known that anionic detergents, including fatty acids, are toxic to bacteria (13, 29) . The fact that surfactant activity increases with chain length of fatty acids to a maximum at C,4 or C,6 and then decreases above C,6 (13) corresponds with the inhibition pattern we obtained for both FA5 and NM33 (Table 4) . Also, realizing the detergent nature of the monoacyl derivative of PE, but not of PE itself, one can hypothesize that gonococcal self-inhibition is surfactant in nature. However, it is possible that factors other than physiochemical activity (surface tension) may be involved. Freese et al. attribute the mechanism of lipophilic antimicrobial activity to the inhibition of substrate transport into the cell, thereby preventing oxidative phosphorylation (10) .
We have not shown the mechanism by which FFA are produced, but the chromatographic evidence (Fig. 3) were harvested during exponential growth phase in broth and their lipids were chromatographed, FFAs were readily apparent (data not shown).
The Neisseria more closely resemble grampositive than typical gram-negative organisms in their sensitivity to medium-and to longchain fatty acids (29) . Since mutations or physical methods that disrupt the integrity of the outer membranes of E. coli and Salmonella typhimurium render them sensitive to mediumand long-chain fatty acids, the resistance of these organisms to C10 to C18 fatty acids has been attributed to the penetration barrier composed by their outer envelope structure (10, 29) . The susceptibility of Neisseria to antibiotics also approximates the levels found in most gram-positive species. These observations suggest a unique structure of the outer membranes of the Neisseria, which otherwise appear to be typically gram negative in structure by electron microscopy (16) and chemical analysis (20) .
Routine cultures of gonococci grown on chocolate agar or GCBDS media rarely survive more than 48 h of incubation. Although we cannot exclude the presence of other toxic metabolites or autolytic enzymes (27) , our demonstration of the production of self-inhibitory lipids during growth may partially explain the short survival of most gonococcal cultures.
